Texas Reports Continued measles Incidence with Fifty new cases
On Mar. 21, 2025, the Texas Department of State Health Services (DSHS) reported updated information about an outbreak…
-
-
Tennessee Department of Health Confirmed 1st Measles Case in the State
On Mar. 21 , 2025, the Tennessee Department of Health confirmed the state’s first measles case in 2025…
-
Ohio Department of Health Reported First Case of Measles
On Mar. 20, 2025, Ohio Department of Health (ODH) reported the state’s first measles case of 2025. The…
-
First measles case in Michigan confirmed in Oakland County
On Mar. 14, 2025, the Michigan Department of Health and Human Services (MDHHS) and Oakland County Health Division…
-
Oklahoma Department of Health reported Additional Measles Cases identified
On Mar. 14, 2025, the Oklahoma State Department of Health (OSDH) received notification of two more probable measles…
-
One Case of Measles Confirmed in a Kansas Resident
On Mar. 13, 2025, the Kansas Department of Health and Environment (KDHE) and the Stevens County Health Department…
-
New York State Department of Health Reported First Case of Measles in New York State Outside of New York City in 2025
On Mar. 11, 2025, the New York State Department of Health today announced the first case of measles…
-
‘A political division, not a physical one, determined who got measles and who didn’t’: Lessons from Texarkana’s 1970 outbreak
On Mar. 11, 2025, in an excerpt from his book Booster Shots (Penguin Random House), pediatrician and infectious…
-
First Cases of Measles in Reported in Oklahoma
On Mar. 11, 2025, the Oklahoma State Department of Health (OSDH) reported the first two measles cases in…
-
Texas Reported nearly 200 cases of the measles in current outbreak
On Mar. 7, 2025, the Texas Department of State Health Services reported updated information about an outbreak of…
-
Texas announced more than 120 cases of the measles and first death
On Feb. 26, 2025, the Texas Department of State Health Services reported the first death from measles in…
-
St. Judes Reports Promising results from first prenatal therapy for spinal muscular atrophy
On Feb. 19, 2025, scientists at St. Jude Children’s Research Hospital report results from a promising new approach…
-
Biotechnology | COVID-19 | Infectious Disease | Influenza | Measles | Polio | Vaccine
Louisiana Surgeon General ignores science, will not promote vaccines
On Feb. 13, 2025, Ralph L. Abraham, MD, the Louisiana Surgeon General announced that the state will no…
-
CIRM Awards Nearly $100 Million to Boost Discovery, Translational, and Clinical Disease Research
On Jan. 30, 2025, the California Institute for Regenerative Medicine (CIRM) announced it has awarded nearly $100 million…
-
Biotechnology | Diagnostics | Disease | FDA | Therapeutics
FDA approved Alhemo® injection as once-daily prophylactic treatment to reduce frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B
On Dec. 20, 2024, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) had approved Alhemo®…
-
COVID-19 linked to more heart complications than flu, RSV
On Dec. 16, 2024, a study published in BMC Cardiovascular Disorders shows that pediatric and young adult COVID-19…
-
CIRM Awarded $29.7 Million to Advance rare pediatric disease Clinical Projects
On Nov. 21, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had approved awarding $29.7 million to…
-
FDA Approved First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency
On Nov. 14, 2024, the U.S. Food and Drug Administration approved PTC Therapeutics’ Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated…
-
U.S. FDA Approved Pfizer’s HYMPAVZI™ (marstacimab-hncq) for Treatment of Adults and Adolescents with Hemophilia A or B
On Oct. 11, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved HYMPAVZI™ (marstacimab-hncq)…
-
Parents want help preventing their children from developing hereditary health conditions
On Aug. 26, 2024, the University of Michigan (UM) announced that one in five parents say their child…
-
Biotechnology | Disease | FDA | Neurology | Non-Profit Research | Oncology
FDA Approved Drug Targeting Johns Hopkins-Discovered Brain Cancer Gene Mutation
On Aug. 6, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved vorasidenib (Voranigo, Servier…
-
FDA approved new antibiotic for three different uses
On Apr. 3, 2024, the U.S. Food and Drug Administration approved Basilea Pharmaceutica’s Zevtera (ceftobiprole medocaril sodium for…
-
Biotechnology | COVID-19 | Diagnostics | HIV | Infectious Disease | Influenza | Measles | Polio | Vaccine | Women's Health
Global child deaths reached historic low in 2022
On Mar. 12, 2024, the United Nations Inter-agency Group for Child Mortality Estimation (UN IGME) reported that the…
-
Flu vaccination during pregnancy decreased flu hospitalizations and emergency visits in infants younger than 6 months
On Dec. 18, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced a study that showed…
-
CDC | Life Science History | Measles | WHO
Global measles threat continued to grow as another year passed with millions of children unvaccinated
On Nov. 16. 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that Following years of…
-
FDA approved first treatment for patients with rare inherited blood clotting disorder
On Nov. 9, 2023, the U.S. Food and Drug Administration approved ‘ Takeda PharmaceuticalsVAdzynma, the first recombinant (genetically…
-
U.S. CDC reported high rates of child flu hospitalizations recorded in 2022-2023 season
On Oct. 20, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that among children and…
-
Purdue named new pediatric cancer research center for the late Tyler Trent
On Oct. 14, 2023, Purdue University ensured that the memory of the former graduate and devoted Boilermaker football…
-
European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older
On Sept. 7, 2023, Merck announced that the European Commission (EC) had approved an expanded indication for ERVEBO…
-
COVID-19 vaccination and boosting during pregnancy benefits pregnant women and newborns
On Aug. 11, 2023, a study funded by the National Institute of Allergy and Infectious Diseases (NIAID) reported…
![European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older](https://lifesciencehistory.com/wp-content/uploads/2022/08/european_commission_logo-768x768.jpg){kind=logo}